A pioneering monoclonal antibody facility for Rwanda marks a pivotal step toward scalable, locally driven production of ...

Bora Biologics, a contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, is ...

The expansion adds 8,075 square feet of state-of-the-art GMP manufacturing space to the San Diego biologics manufacturing ...

The facility boasts 100% process water reduction ... of Bayer’s state-of-the-art Single Use Technology biopharmaceutical manufacturing Cell Culture Technology Center in 2021.

ImmunityBio Inc. leadership agreed to add an independent member to its board to end shareholder allegations that they caused ...

The Global Biologics CDMO Market is expected to witness a growth rate of 14-16% in the next five years. Growing ...

The Global Single-use Bioreactors Market is set to witness a healthy growth rate of 20% by 2029. Technological innovations ...

The expansion adds 8,075 square feet of state-of-the-art GMP manufacturing ... provider of GMP facility design and GxP systems implementation and compliance for the biopharmaceutical industry ...

Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...

Robust governance is the cornerstone of sustainable business development. In 2024, Innovent further refined its ESG ...

"We are proud to partner with Kaida BioPharma on the development of KAD101,” said Prof. Vladas Algirdas Bumelis, CEO and ...

South Korea’s exports of pharmaceutical products, one of the country’s key strategic sectors, stood at US$9.59 billion in ...